FOSB, FosB proto-oncogene, AP-1 transcription factor subunit, 2354
N. diseases: 278; N. variants: 0
Source: ALL
| Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Musculoskeletal Diseases | Disease or Syndrome | 1 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | ||||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 4 | 0.300 | None | 1.000 | 1 | 2009 | 2009 | ||||||
|
disease | Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 5 | 0.020 | None | 1.000 | 2 | 2017 | 2018 | ||||||
|
disease | Neoplastic Process | 5 | 0.010 | None | 1.000 | 1 | 2013 | 2013 | |||||||
|
disease | Neoplasms | Neoplastic Process | 10 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | ||||||
|
disease | Neoplastic Process | 12 | 0.080 | None | 0.750 | 8 | 2014 | 2019 | |||||||
|
disease | Female Urogenital Diseases and Pregnancy Complications | Injury or Poisoning | 13 | 0.300 | None | 1.000 | 1 | 2015 | 2015 | ||||||
|
group | Neoplasms; Cardiovascular Diseases | Neoplastic Process | 15 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | Disease or Syndrome | 15 | 0.300 | None | 1.000 | 1 | 2006 | 2006 | ||||||
|
disease | Neoplasms | Neoplastic Process | 18 | 1 | 0.030 | None | 0.667 | 3 | 2014 | 2018 | |||||
|
disease | Musculoskeletal Diseases | Neoplastic Process | 18 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
disease | Musculoskeletal Diseases | Disease or Syndrome | 18 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | ||||||
|
disease | Neoplasms | Neoplastic Process | 22 | 0.020 | None | 1.000 | 2 | 2018 | 2020 | ||||||
|
disease | Nervous System Diseases | Disease or Syndrome | 23 | 0.300 | None | 1.000 | 1 | 1999 | 1999 | ||||||
|
disease | Neoplasms | Neoplastic Process | 26 | 0.030 | None | 1.000 | 3 | 2014 | 2019 | ||||||
|
disease | Neoplasms | Neoplastic Process | 26 | 0.020 | None | 0.500 | 2 | 2015 | 2017 | ||||||
|
disease | Neoplasms | Neoplastic Process | 26 | 0.020 | None | 0.500 | 2 | 2015 | 2017 | ||||||
|
disease | Neoplasms | Neoplastic Process | 29 | 0.020 | None | 0.500 | 2 | 2015 | 2017 | ||||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 30 | 1 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | Disease or Syndrome | 32 | 0.300 | None | 1.000 | 1 | 2006 | 2006 | ||||||
|
disease | Neoplasms | Neoplastic Process | 33 | 0.020 | None | 1.000 | 2 | 2015 | 2017 | ||||||
|
disease | Neoplasms | Neoplastic Process | 33 | 0.020 | None | 1.000 | 2 | 2015 | 2017 | ||||||
|
disease | Neoplasms | Neoplastic Process | 36 | 4 | 0.030 | None | 0.333 | 3 | 2015 | 2018 | |||||
|
phenotype | Cardiovascular Diseases | Disease or Syndrome | 39 | 2 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
disease | Neoplasms | Neoplastic Process | 41 | 0.010 | None | 1.000 | 1 | 2015 | 2015 |